{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T04:07:19Z","timestamp":1749442039686,"version":"3.37.3"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T00:00:00Z","timestamp":1573430400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T00:00:00Z","timestamp":1573430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s13365-019-00808-0","type":"journal-article","created":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T17:03:37Z","timestamp":1573491817000},"page":"281-283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Uveomeningeal syndrome in a healthy, young male: an unusual presentation of West Nile virus"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9713-4213","authenticated-orcid":false,"given":"Lindsey","family":"Rearigh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin","family":"Kedar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara H.","family":"Bares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,11]]},"reference":[{"issue":"3","key":"808_CR1","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1001\/archopthalmol.2011.1630","volume":"130","author":"Armin R. Afshar","year":"2012","unstructured":"Afshar et al (2012) Use of intravitreous bevacizumab to treat macular edema in West Nile virus chorioretinitis. Arch Ophthalmol 130(3)","journal-title":"Archives of Ophthalmology"},{"key":"808_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1086\/382884","volume":"38","author":"W Anninger","year":"2004","unstructured":"Anninger W, Lubow M (2004) Visual loss with West Nile virus infection: a wider spectrum of a \u2018new\u2019 disease. Clin Infect Dis 38:7. https:\/\/doi.org\/10.1086\/382884","journal-title":"Clin Infect Dis"},{"key":"808_CR3","unstructured":"Chan, Limstrom, Tarasewicz, Lin (2006) Ocular features of West Nile virus infection in North America. American Academy of Ophthalmology, Manuscript no. 2005-983."},{"issue":"1","key":"808_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.survophthal.2004.10.001","volume":"50","author":"S Garg","year":"2005","unstructured":"Garg S, Jampol LM (2005) Systemic and intraocular manifestations of West Nile virus infection. Surv Ophthalmol 50(1):3\u201313. https:\/\/doi.org\/10.1016\/j.survophthal.2004.10.001","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"808_CR5","doi-asserted-by":"publisher","first-page":"e0148898","DOI":"10.1371\/journal.pone.0148898","volume":"11","author":"Rodrigo Hasbun","year":"2016","unstructured":"Hasburn et al (2016) West Nile virus retinopathy and associations with long term neurological and neurocognitive sequelae. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0148898","journal-title":"PLOS ONE"},{"key":"808_CR6","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/j.ophtha.2004.03.032","volume":"111","author":"Khairallah","year":"2004","unstructured":"Khairallah et al (2004) Chorioretinal involvement in patients with West Nile virus infection. Ophthalmology 111:2065\u20132070","journal-title":"Ophthalmology"},{"key":"808_CR7","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/sj.eye.6702355","volume":"21","author":"Khairallah","year":"2006","unstructured":"Khairallah et al (2006) Linear pattern of West Nile virus-associated chorioretinitis is related to retinal nerve fibres organization. Eye 21:952\u2013955","journal-title":"Eye"},{"issue":"6","key":"808_CR8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/09273940701798488","volume":"15","author":"Moncef Khairallah","year":"2007","unstructured":"Khairallah M, Yahia SB, Letaief M, Attia S, Kahloun R, Jelliti B, Zaouali S, Messaound R (2007) A prospective evaluation of factors associated with chorioretinitis in patietns with West Nile virus infection. Ocul Immunol Inflamm 15(6):435\u2013439. https:\/\/doi.org\/10.1080\/09273940701798488","journal-title":"Ocular Immunology and Inflammation"},{"key":"808_CR9","doi-asserted-by":"publisher","unstructured":"Leis AA, Stokic DS (2012) Neuromuscular manifestations of West Nile virus infection. Front Neurol 3. https:\/\/doi.org\/10.3389\/fneur.2012.00037","DOI":"10.3389\/fneur.2012.00037"},{"key":"808_CR10","unstructured":"Narayanaswami, Pushpa et al (2004) West Nile meningitis\/encephalitis: P05.109: experience with corticosteroid therapy. Am Acad Neurol 62(7):A404. https:\/\/doi.org\/00006114-200404001-01013"},{"key":"808_CR11","first-page":"6","volume":"36","author":"V Pyrogos","year":"2009","unstructured":"Pyrogos V, Younus F (2009) High-dose steroids in the management of acute flaccid paralysis due to West Nile virus infection. Scand J Infect Dis 36:6\u20137","journal-title":"Scand J Infect Dis"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-019-00808-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13365-019-00808-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-019-00808-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T01:22:25Z","timestamp":1604971345000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13365-019-00808-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,11]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["808"],"URL":"https:\/\/doi.org\/10.1007\/s13365-019-00808-0","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"type":"print","value":"1355-0284"},{"type":"electronic","value":"1538-2443"}],"subject":[],"published":{"date-parts":[[2019,11,11]]},"assertion":[{"value":"5 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}